NEW YORK—June 12, 2008
Mr. Immelt has been named one of the “World’s Best CEOs” three times by Barron’s, and since he began serving as chief executive officer, GE has been named “America’s Most Admired Company” in a poll conducted by Fortune magazine and one of “The World’s Most Respected Companies” in polls by Barron’s and the Financial Times.
“GE is a global leader in medical diagnostic technology and biosciences,” said Louis A. Shapiro, president and chief executive officer of Hospital for Special Surgery. “Mr. Immelt’s commitment to continued innovation is admirable. In the area of orthopedics, GE has contributed immensely to the advancement of diagnostics and the ability of surgeons to more precisely develop a customized approach to each patient.”
“Hospital for Special Surgery works closely with GE Healthcare on exploring pioneering uses of magnetic resonance imaging (MRI) in orthopedics,” said Thomas P. Sculco, M.D., surgeon-in-chief at Hospital for Special Surgery. “Our extensive staff expertise and patient volume make for an ideal collaborative research environment. We have been working together to create the next generation of diagnostic approaches in orthopedics.”
Joseph M. Hogan, president and CEO of GE Healthcare, will also be attending the 25th Annual Tribute Dinner and serving as dinner co-chair along with William R. Salomon, a Special Surgery board member and honorary chairman at Citigroup. Mr. Hogan began his career at GE in 1985 and advanced through a series of leadership roles. As head of GE Healthcare, Mr. Hogan currently oversees a $17 billion business.
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the eighth consecutive year) and No. 3 in rheumatology by U.S. News & World Report (2017-2018). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.